Lv2
150 积分 2025-09-15 加入
Immunogenomic cancer evolution: A framework to understand cancer immunosuppression
1个月前
已完结
FGF21 reverses MASH through coordinated actions on the CNS and liver
3个月前
已完结
Glutamine synthetase loss in β-catenin–mutant hepatocellular carcinoma promotes tumor burden through macrophage metabolic reprogramming
5个月前
已完结
The origin of hepatocellular carcinoma depends on metabolic zonation
6个月前
已完结
Spatial metabolic gradients in the liver and small intestine
7个月前
已完结
[High-mobility group protein 1 promotes diethylnitrosamine-induced liver cancer formation in mice by activating mitochondrial biogenesis]
7个月前
已完结
Ribosomal protein L32 enhances hepatocellular carcinoma progression
7个月前
已完结
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
8个月前
已完结
皖公网安备34019202002308
